Download
virulence and disease n.
Skip this Video
Loading SlideShow in 5 Seconds..
Virulence and disease PowerPoint Presentation
Download Presentation
Virulence and disease

Virulence and disease

307 Vues Download Presentation
Télécharger la présentation

Virulence and disease

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Virulence and disease What can evolution tell us about disease and medicine?

  2. Outline: virulence and disease • Pathogen evolution • Origins of novel pathogens • Causes of virulence (esp. trade-off) • Evolution of antibiotic resistance • Evolution and human health • Disorders due to changes in environment • Diseases as defenses • Disorders due to sexual conflict

  3. I. Pathogen evolution: eluding the immune system - influenza Do amino acid substitutions occur at antigenic sites? Sample flu lineages from 1968 to 1987. Surviving Extinct Antigenic sites 33 31 Non-antigenic sites 10 35 Hemagglutinin (HA): cell entry Neuroaminidase (NA): cell exit

  4. Evolution of antigenic sites What kind of substitution in hemagglutinin? 18 codons with excess replacement (dN > dS): Figure 13.4

  5. IB: Origins of novel pathogens - influenza • Three types of influenza viruses: • A and B have 8 RNA strands, C has 7 • type A and B encode HA and NA, C does not • A and B can be severe, C generally mild • Hosts: • type A: humans, swine, horses, waterfowl, gulls • type B: humans and seals • type C: humans and swine • Flu A viruses are classified by HA type (1-15) and NA type (1-9) • only H1, H2, H3 and N1, N2 in humans (until recently)

  6. Flu pandemics • 1918 Spanish flu (40m deaths) H1N1 • 1957 Asian (1m deaths) H2N2 • 1968 Hong Kong H3N2 • 1977 Russian H1N1 • 1997 Avian (22 deaths) H5N1

  7. Where do pandemics come from? Phylogeny of nucleoprotein gene of influenza A.

  8. A role for pigs? Sialic acid – galactose on epithelial cell surface key to infection – binding site for hemagglutinin (HA) Can bind two different ways. Avian 2-3. Human 2-6.

  9. H3 1968 from birds Phylogeny of flu A hemagglutinin genes

  10. High virulence = rapid growth rate of virus Low virulence = slow growth rate of virus leads to severe host illness and/or death leads to slow development of illness or little effect on host IC. What causes virulence? Virulence: : tendency to reduce survival or reproductive capacity of host

  11. increased chance of transmission at each copulation decreased # copulations before death of host Cost to virus Benefit to virus Why doesn’t HIV evolve to become more virulent? With high virulence you get: many virions/ml blood rapid illness and death of host

  12. Evolution of Virulence: Australia’s plague of rabbits 13 wild introduced in 1858. 9 years later, 50 km spread. 1870s: 150 km / yr

  13. Myxoma virus

  14. Effect of myxoma virus on rabbits – 1951-1953

  15. Virulence of field strains Tests carried out on domestic rabbits

  16. Trade-off hypothesis of virulence

  17. Rabbit resistance evolves

  18. What is the optimal level of virulence? But why is there a different balance in different pathogens--why are some more virulent than others? Why don’t some pathogens seem to become less virulent?

  19. What is the optimal level of virulence? Water-borne diseases

  20. What is the optimal level of virulence? Vector-borne diseases

  21. Second virulence hypothesis: short-sighted evolution

  22. Third virulence hypothesis: coincidental

  23. I-D. Evolution of antibiotic resistance • 70% of bacterial infections requiring hospitalization are resistant to some antibiotic • Sepsis (infected blood / tissue) rates tripled in US from 1979 to 2000

  24. Acquisition of anti-biotic resistance? Time to resistance? Drug Introduction Resistance Penicillin 1943 1946 Streptomycin 1945 1959 Tetracycline 1948 1953 Vancomycin 1956 1988 Methicillin 1960 1961 Cefataxime 1985 1988

  25. Modes of resistance Drug action resistance Tetracycline: blocks translation ribosome mutation cellular pumps upregulated Penicillin blocks cell walls beta-lactamase digests drug cipro DNA packing mutation to enzymes (fluoroquinolones) (inhibits topoisomerase)

  26. Efflux pumps

  27. Experimental test of cost of resistance: Schrag (1997)

  28. Initial competition without antibiotics Time (generations)

  29. After many generations in the lab?

  30. After many generations in the lab?

  31. An evolutionary mystery: vancomycin resistance Vancomycin: 32 years before resistance seen. 500K staph infections per year in hospitals. By 1990s, commonly resistant to other antibiotics. Until recently, the last-resort antibiotic when other resistant. Mechanism: blocks cell-wall biosynthesis by forming complex with peptidoglycans Cross-linker: D-alanine D-alanine di-peptide Gram-positive bacteria

  32. Mechanism of resistance

  33. Vancomycin resistance

  34. Origins of vancomycin resistance: comparison of amino acid sequences Numbers above: sequence similarity to VanA from E. foecium. Below: GC%.

  35. Source of resistance

  36. Antibiotic resistance summary

  37. Hypotheses to explain human disorders Always deleterious: Sometimes deleterious: Only seem deleterious, actually a defense

  38. G x E: Myopia (near-sightedness) Hypothesis: myopia is environment dependent Test: Barrow, Alaska Test in 1970 (35 years later) Age: Myopic Not myopic % 6-35 146 202 42 35+ 8 152 5

  39. II. Diseases are really defenses: “Morning sickness” • “nausea and vomiting of pregnancy”, or NVP • About 2/3 of all pregnant women worldwide affected • All hours (not just morning) • Affects healthy mothers, who have healthy babies • seems negative: • reduced food intake, reduced activity level • why persistent and common?

  40. Proportion with NVP Post-menstrual week of pregnancy Sensitive Fetal organ Post-menstrual week of pregnancy Diseases are really defenses: “Morning sickness” Prediction 1: NVP most severe when need for protection greatest Sherman and Flaxman 2002

  41. Diseases are really defenses: “Morning sickness” Percentage of pregnancies with miscarriage Study **Prediction 2: NVP should be associated with positive pregnancy outcomes Sherman and Flaxman 2002

  42. Evolution of menopause • 7 million oogonia at fifth fetal month • 2 million oocytes at birth: meiotic prophase • 400,000 at puberty • 400 lost to ovulation • remainder degenerate (atresia)– why? • when few remain, menopause • Hypotheses: • proximate: mitochondrial damage leads to apoptosis (but why aren’t there more to start with?) • adaptive??

  43. Study questions • If you compare the pattern of mutations in a virus over time, what would indicate neutral evolution? What would indicate that selection was at work? • The hypothesis is that the 1918 flu virus incorporated many avian flu elements. Two hypotheses could be formulated: the 1918 flu involved recombination between human and avian flu strains, or the 1918 flu involved an avian strain shifting to humans. Imagine that you had access to flu sequences from 1900, 1905, 1910, and 1918 for ducks and humans and that you built two phylogenies, one for nucleoprotein and one for hemagglutinin. Sketch what the phylogenies would need to look like to support each hypothesis. • Explain why virulence rapidly declined for myxomatosis in Australian rabbits using the requirements of natural selection. • The 1918-1920 flu epidemic killed 40 million people. Formulate three hypotheses for why this virus did not continue killing humans at such high rates.

  44. Study questions • Why do some pathogens evolve to become less virulent but not others? Explain why some of the key variables include mode of transmission and primary hosts. • Consider two diseases. In one case, hosts are infected by a single strain at a time. In the other case, hosts are infected by multiple strains at one time. How would you predict this difference to affect the evolution of virulence? • You are investigating the hypothesis that antibiotic resistance in a bacterial infection originated via horizontal gene transfer. Explain how you would use phylogenies to assess this.

  45. References Frank, Steven A. 2002. Immunology and evolution of infectious disease. Princeton University Press. Guardabassi, L. et al. 2005. Glycopeptide VanA Operons in Paenobacillus strains isolated from soil. Antimicrobrial agents and chemotherapy 49:4227-4233. Hay, A. J. et al. 2001. The evolution of human influenza viruses. Philosophical transactions of the Royal Society Series B 356:1861-1870. Hurtado, A. M. et al. 1999. The evolution ecology of childhood asthma. In Trevathan, W. R. et al., eds. Evolutionary medicine. Oxford University Press. Launay, A. et al. 2006. Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut in gnotobiotic mice. Antimicrobial agents and chemotherapy 50:1054-1062. Lewis, D. 2006. Avian flu to human influenza. Annual review of medicine 57:139-154. Nesse, R. M. and Williams, G. C. 1996. Why we get sick: the new science of Darwinian medicine. Random House, New York. Sherman and Flaxman. 2002. Nausea and vomiting of pregnancy in an evolutionary perspective. American Jr of Ostetrics and Gynecology 186: S190-S197. Stearns, S. and Ebert, D. 2001. Evolution in health and disease: a work in progress. Quarterly review of biology 76:417-432. Walsh, C. T. et al. 1996. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Current biology 3:21-28. White, D. G. et al., eds. 2005. Frontiers in Antimicrobial Resitance. American Society for Microbiology.